Vivos Therapeutics (VVOS) Stock Price, Quote, News & History | Benzinga

Vivos Therapeutics Inc (VVOS) Stock Price, Quote, News & History

VVOSNASDAQ

Trade with Public

Trade with Public

$0.4196

-0.0124-2.87%

At close: Jul 13, 5:00 PM EST

$0.4300

0.01042.48%

After Hours: 6:20 PM EST

OverviewNews Earnings Events Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$0.45

Close

$0.42

Volume / Avg.

173.64K / 1.66M

Day Range

$0.41 - $0.47

52 Wk Range

0.38 - 7.95

Market Cap

$5.97M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

37

Short Interest

10.56%

Days to Cover

1

Recent Vivos Therapeutics Inc News

Vivos Extends Streeterville Financing Deal Through Aug. 31, Reaffirms Plan To Convert Up To $4.5M Debt Into Preferred And Common Stock

Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ:VVOS), a leading medical device and healthcare services company focused on the treatment of breathing-related sleep disorders and associated

Benzinga News-desk

CrowdStrike To Surge Nearly 25%? Here Are 10 Notable Analyst Calls From Thursday

Top Wall Street analysts updated ratings on CRWD, OLLI, XPO, SHAK, UNH, PVH, VVOS, and SYRE. See analyst ratings page for full details.

Avi Kapoor

Qorvo To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Wednesday

Wall Street analysts changed their outlook on top names. For all rating changes, see analyst ratings page. Vivos, Airbnb, Gitlab, Frontline, Qorvo, Valmont, Chubb, and UnitedHealth saw price target changes and upgrades/downgrades.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-17.48M

Investing Cash Flow (TTM)

-7.42M

Financing Cash Flow (TTM)

24.67M

Free Cash Flow (TTM)

-19.71M

Capital Expenditure (TTM)

-2.24M

Net Change in Cash (TTM)

-232.00K

Analyst Trends and Forecast

2

Apr

1

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$15.93M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

0.25

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-515.41%

Earnings Yield % (FWD)

-262.52%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$0.08

Company Debt

Total Debt

$7.72M

LT Debt

$418.00K

LT Debt Issuance (TTM)

$12.07M

LT Debt Repayment (TTM)

-$448.00K

Total Cash

$2.11M

Debt to Equity

-

Issuance of Debt (TTM)

$11.63M

Repayment of Debt (TTM)

-$448.00K

Key Statistics

Open

$0.45

Close

$0.42

Volume / Avg.

173.64K / 1.66M

Day Range

$0.41 - $0.47

52 Wk Range

0.38 - 7.95

Market Cap

$5.97M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

37

Short Interest

10.56%

Days to Cover

1

About

Sector

Health Care

Industry

Health Care Providers & Services

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Vivos Therapeutics (VVOS) stock?

A

You can purchase shares of Vivos Therapeutics (NASDAQ:VVOS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Vivos Therapeutics (VVOS) competitors?

A

There are no as such competitors for Vivos Therapeutics.

Q

What is the forecast, or price target, for Vivos Therapeutics (VVOS) stock?

A

Vivos Therapeutics has a consensus price target of $3.87.

Q

What is the current price for Vivos Therapeutics (VVOS)?

A

The stock price for Vivos Therapeutics (NASDAQ: VVOS) is $0.43 last updated July 13, 2026 at 6:20 PM EDT.

Q

Does Vivos Therapeutics (VVOS) pay a dividend?

A

There are no upcoming dividends for Vivos Therapeutics.

Q

When is Vivos Therapeutics (NASDAQ:VVOS) reporting earnings?

A

Vivos Therapeutics does not have any upcoming earnings scheduled.

Q

Is Vivos Therapeutics (VVOS) going to split?

A

There is no upcoming split for Vivos Therapeutics.

Q

What sector and industry does Vivos Therapeutics (VVOS) operate in?

A

Vivos Therapeutics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.